多发性硬化症患者中不孕是否更常见?对辅助生殖技术利用的启示
基于以色列Clalit健康服务数据库,纳入2005至2021年18-45岁女性多发性硬化症患者1309例,按年龄1:10匹配普通人群对照13090例。多发性硬化症组不孕患病率为15.4%(202/1309),与对照组16.3%(2129/13090)相似(P=0.436);体外受精和卵巢刺激的使用率两组亦相似。结论提示多发性硬化症女性不孕率及辅助生殖技术使用率与普通人群无显著差异。
要点
- 多发性硬化症女性不孕患病率15.4%(202/1309)与普通人群16.3%(2129/13090)相似(P=0.436)。
- 多发性硬化症组体外受精使用率8.1%与对照组7.2%相似(P=0.240)。
- 多发性硬化症组卵巢刺激使用率13.8%与对照组14.3%相似(P=0.624)。
核心结论
- 多发性硬化症女性与普通人群的不孕率及生育治疗使用率相似,提示其不孕情况与普通人群无差异,且未过度使用辅助生殖技术。
研究设计与样本
- 数据提取自以色列Clalit健康服务数据库,收集2005至2021年所有18-45岁女性多发性硬化症患者的诊断、治疗、不孕原因及生育治疗使用情况。
- 每例患者按年龄1:10比例与普通人群参考女性匹配,比较两组不孕患病率。
- 采用单变量和多变量统计检验分析多发性硬化症与体外受精及卵巢刺激等生育治疗的关联。
主要发现
- 研究期间共纳入1309例多发性硬化症患者与13090例年龄匹配的普通人群对照,平均年龄29±7.8岁。
- 多发性硬化症组总体不孕患病率为15.4%(202/1309),普通人群为16.3%(2129/13090),两组相似(P=0.436)。
- 多发性硬化症组与匹配对照组的体外受精使用率分别为8.1%与7.2%(P=0.240),卵巢刺激使用率分别为13.8%与14.3%(P=0.624),均相似。
临床怎么用
- 原文结论指出多发性硬化症女性不孕率与普通人群无差异,且未过度使用辅助生殖技术,为临床提供安慰。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Is fertility affected in women with multiple sclerosis (MS), and what is their usage of assisted reproductive technology (ART)? DESIGN: Data regarding multiple sclerosis and ART usage among patients with multiple sclerosis were extracted from the Israeli health maintenance organization Clalit Health Service database. Data regarding the diagnosis and treatment of multiple sclerosis, cause of infertility and use of fertility treatments were collected for all female multiple sclerosis patients aged 18-45 years between 2005 and 2021. Each patient was matched by age in a 1:10 ratio with reference women from the general population. The prevalence of infertility was compared between the two groups. Univariate and multivariate statistical tests were used to analyse the association between multiple sclerosis and fertility treatments including IVF and ovarian stimulation. RESULTS: During the study period, 1309 multiple sclerosis patients were compared with 13,090 controls from the general population matched for age. The mean age was 29 ± 7.8 years. The overall prevalence of infertility was 15.4% (202/1309) among the multiple sclerosis patients, similar to the general population (16.3%; 2129/13090) (P = 0.436). The prevalence of IVF and ovarian stimulation was similar among multiple sclerosis patients and matched controls from the general population (8.1% versus 7.2%, P = 0.240; 13.8% versus 14.3%; P = 0.624, respectively). CONCLUSIONS: The results show similar rates of infertility and fertility treatments among multiple sclerosis patients and the general population. This provides reassurance that fertility among women with multiple sclerosis does not differ from that of women in the general population, and indicates there is no excessive usage of ART.
引用
- Skvirsky S, Winer ZM, Baratz SL, et al. Is infertility more common among patients with multiple sclerosis? Implications for utilization of assisted reproductive techniques. Reprod Biomed Online. 2024. PMID: 38897135. doi:10.1016/j.rbmo.2024.103980
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。